Brain-targeted delivery of Valsartan using solid lipid nanoparticles labeled with Rhodamine B; a promising technique for mitigating the negative effects of stroke

References

• Abbaspour M, Iraji P, Mahmoudi Z, et al. (2021). Design and physico-mechanical evaluation of fast-dissolving valsartan polymeric drug delivery system by electrospinning method. Iran J Basic Med Sci 24:1–13.
   PubMed Web of Science ®Google Scholar
• Aboud HM, El Komy MH, Ali AA, et al. (2016). Development, optimization, and evaluation of carvedilol-loaded solid lipid nanoparticles for intranasal drug delivery. Am Assoc Pharm Sci 17:1353–65.
   Google Scholar
• Al Ashmawy AG, Eissa NG, El Nahas HM, Balata GF. (2021). Fast disintegrating tablet of Doxazosin Mesylate nanosuspension: preparation and characterization. J Drug Delivery Sci Technol 61:102210.
   Web of Science ®Google Scholar
• Alajami HN, Fouad EA, Ashour AE, et al. (2022). Celecoxib-loaded solid lipid nanoparticles for colon delivery: formulation optimization and in vitro assessment of anti-cancer activity. Pharmaceutics 14:131.
   PubMed Web of Science ®Google Scholar
• Anarjan N, Malmiri HJ, Nehdi IA, et al. (2015). Effects of homogenization process parameters on physicochemical properties of astaxanthin nanodispersions prepared using a solvent diffusion technique. Int J Nanomed 10:1109–18.
   PubMed Web of Science ®Google Scholar
• Asasutjarit R, Lorenzen SI, Sirivichayakul S, et al. (2007). Effect of solid lipid nanoparticles formulation compositions on their size, zeta potential and potential for in vitro pHIS-HIV-Hugag transfection. Pharm Res 24:1098–107.
   PubMed Web of Science ®Google Scholar
• Barakat W, Safwet N, El-Maraghy NN, Zakaria MNM. (2014). Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade. Eur J Pharmacol 724:43–50.
   PubMed Web of Science ®Google Scholar
• Basak SC, Kumar KS, Ramalingam M. (2008). Design and release characteristics of sustained release tablet containing metformin HCl. Braz J Pharm Sci 44:477–83.
   Google Scholar
• Behbahani ES, Ghaedi M, Abbaspour M, Rostamizadeh K. (2017). Optimization and characterization of ultrasound assisted preparation of Curcumin-loaded solid lipid nanoparticles: application of central composite design, thermal analysis and X-ray diffraction techniques. Ultrason Sonochem 38:271–80.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Reddy P. (2019). Effect of surfactant on azithromycin dihydrate loaded stearic acid solid lipid nanoparticles. Turk J Pharm Sci 16:425–31.
   PubMed Web of Science ®Google Scholar
• Bibi M, Ud Din F, Anwar Y, et al. (2022). Cilostazol-loaded solid lipid nanoparticles: bioavailability and safety evaluation in an animal model. J Drug Delivery Sci Technol 74:103581.
   Web of Science ®Google Scholar
• Chandana MP, Ramana MV, Rao NR. (2021). Formulation and evaluation of Valsartan solid lipid nanoparticles. J Drug Deliv Ther 11:103–8.
   Google Scholar
• Da Silva AR, De Oliveira AM, Augusto F, Jorge RA. (2011). Effects of preparation conditions on the characteristics of poly(lactide-co-glycolide) nanospheres loaded with chloro(5,10,15,20-tetraphenylporphyrinato) indium (III). J Nanosci Nanotechnol 11:5234–46.
   PubMed Web of Science ®Google Scholar
• Dahlof B. (2009). Prevention of stroke: new evidence. Eur Heart J Suppl 11:F33–8.
   Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. (2018). Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 10:1–17.
   Web of Science ®Google Scholar
• Duong VA, Nguyen TTL, Maeng HJ. (2020). Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method. Molecules 25:47–81.
   Web of Science ®Google Scholar
• El-Mezayen NS, El-Hadidy WF, El-Refaie WM, et al. (2018). Oral vitamin-A-coupled valsartan nanomedicine: high hepatic stellate cell receptors accessibility and prolonged enterohepatic residence. J Control Release 283:32–44.
   PubMed Web of Science ®Google Scholar
• El-Nahas HM. (2010). Optimization of Eudragit RS microspheres for controlled release of theophylline using response surface methodology. J Pharm Sci Res 2: 663–71.
   Google Scholar
• El-Say KM, Hosny KM. (2018). Optimization of carvedilol solid lipid nanoparticles: an approach to control the release and enhance the oral bioavailability on rabbits. Plos ONE 13:e0203405.
   PubMed Web of Science ®Google Scholar
• Emami J, Mohiti H, Hamishehkar H, Varshosaz J. (2015). Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and BoxBehnken design. Res Pharm Sci 10:17–33. https://pubmed.ncbi.nlm.nih.gov/26430454.
   PubMed Web of Science ®Google Scholar
• Gamal A, Gardouh ARM, Gad S. (2020). Parameter optimization of solid lipid nanoparticles formulation. Rec Pharm Biomed Sci 4:1–7.
   Google Scholar
• Gardouh AR, Sayed HA, Ghorab MM, Abdel-Rahman SGS. (2010). Preparation and characterization of solid lipid micro/nanoparticles. I. Effect of lipid concentration, surfactant type and concentration on physical characteristics of solid lipid micro/nanoparticles. Zagazig J Pharm Sci 19:1–4.
   Google Scholar
• Ghorab M, Gardouh A, Gad S. (2015). Effect of viscosity, surfactant type and concentration on physicochemical properties of solid lipid nanoparticles. Int J Pharm Pharm Sci 7:145–53.
   Google Scholar
• Gupta B, Poudel BK, Pathak S, et al. (2016). Effects of formulation variables on the particle size and drug encapsulation of imatinib-loaded solid lipid nanoparticles. Am Assoc Pharm Scientists 17:652–62.
   Google Scholar
• Hadi NR, Al-Amran FG, Hussien YA, et al. (2015). The cardioprotective potential of valsartan in myocardial ischaemia reperfusion injury. Cent Eur J Immunol 40:159–66.
   PubMed Web of Science ®Google Scholar
• Hanson LR, Fine JM, Svitak AL, Faltesek KA. (2013). Intranasal administration of CNS therapeutics to awake mice. J Visualized Exp 74:4440. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653240/
   Google Scholar
• Hasan AA, Samir RM, Abu-Zaid SS, Abu Lila AS. (2020). Mebeverine hydrochloride loaded chitosan microspheres as potential treatment targeting irritable bowel syndrome: Box-Behnken design optimization. Int J Pharm Invest 10:326–31.
   Web of Science ®Google Scholar
• Hassan H, Bello RO, Adam SK, et al. (2020). Acyclovir-loaded solid lipid nanoparticles: optimization, characterization and evaluation of its pharmacokinetic profile. Nanomaterials 10:1785.
   Web of Science ®Google Scholar
• He H, Yao J, Zhang Y, et al. (2019). Solid lipid nanoparticles as a drug delivery system to across the blood brain barrier. Biochem Biophys Res Commun 519:385–90.
   PubMed Web of Science ®Google Scholar
• Ibrahim TM, Abdallah MH, El-Megrab NA, El-Nahas HM. (2019). Transdermal ethosomal gel nanocarriers; a promising strategy for enhancement of antihypertensive effect of carvedilol. J Liposome Res 29:215–28.
   PubMed Web of Science ®Google Scholar
• Ibrahim TM, Eissa RG, El-Megrab NA, El-Nahas HM. (2021). Morphological characterization of optimized risperidone-loaded in-situ gel forming implants with pharmacokinetic and behavioral assessments in rats. J Drug Delivery Sci Technol 61:1–13.
   Web of Science ®Google Scholar
• Kaur R, Garg T, Malik B, et al. (2016b). Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs. Drug Delivery 23:872–7.
   Web of Science ®Google Scholar
• Kaur P, Garg T, Rath G, et al. (2016a). Development, optimization and evaluation of surfactant-based pulmonary nano lipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design. Drug Deliv 23:1912–25.
   PubMed Web of Science ®Google Scholar
• Kurakula M, Ahmed OA, Fahmy UA, Ahmed TA. (2016). Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies. J Liposome Res 26:288–96.
   PubMed Web of Science ®Google Scholar
• Kushwaha AK, Vuddanda PR, Karunanidhi P, et al. (2013). Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. Biomed Res Int 2013:584549.
   PubMed Web of Science ®Google Scholar
• Llovera G, Roth S, Plesnila N, et al. (2014). Modeling stroke in mice: permanent coagulation of the distal middle cerebral artery. J Visualized Exp 89:51729.
   Google Scholar
• Mai HC, Le TTT, Diep TT, et al. (2018). Development of solid lipid nanoparticles of Gac (Momordica cocochinensis Spreng) oil by nano-emulsion technique. Asian J Chem 3:293–7.
   Google Scholar
• Makoni PA, Kasongo KW, Walker RB. (2019). Short term stability testing of efavirenz-loaded solid lipid nanoparticle (SLN) and nanostructured lipid carrier (NLC) dispersions. Pharmaceutics 11:397.
   PubMed Web of Science ®Google Scholar
• Mannucci S, Boschi F, Cisterna B, et al. (2020). A correlative imaging study of in vivo and ex vivo biodistribution of solid lipid nanoparticles. Int J Nanomed 15:1745–1758.
   PubMed Web of Science ®Google Scholar
• Maqsood S, Ud Din F, Khan S, et al. (2022). Levosulpiride-loaded nanostructured lipid carriers for brain delivery with antipsychotic and antidepressant effects. Life Sci 311:121198.
   PubMed Web of Science ®Google Scholar
• Michel MC, Brunner HR, Foster C, Huo Y. (2016). Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease. Pharmacol Ther 164:1–81.
   PubMed Web of Science ®Google Scholar
• Michel MC, Foster C, Brunner HR, Liu L. (2013). A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists. Pharmacol Rev 65:809–48.
   PubMed Web of Science ®Google Scholar
• Misra S, Chopra K, Sinha V, Medhi B. (2016). Galantamine-loaded solid–lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations. Drug Deliv 23:1434–43.
   PubMed Web of Science ®Google Scholar
• Morsi NM, Ghorab DM, Badie HA. (2013). Brain targeted solid lipid nanoparticles for brain ischemia: preparation and in vitro characterization. Pharm Dev Technol 18:736–44.
   PubMed Web of Science ®Google Scholar
• Nair AB, Shah J, Al-Dhubiab BE, et al. (2021). Clarithromycin solid lipid nanoparticles for topical ocular therapy: optimization, evaluation, and in vivo studies. Pharmaceutics 13:523.
   PubMed Web of Science ®Google Scholar
• Neves AR, Queiroz JF, Weksler B, et al. (2015). Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E. Nanotechnology 26:495103.
   PubMed Web of Science ®Google Scholar
• Olejnik A, Kapuscinska A, Schroeder G, Nowak I. (2017). Physico-chemical characterization of formulations containing endomorphin-2 derivatives. Amino Acids 49:1719–31.
   PubMed Web of Science ®Google Scholar
• Omwoyo WN, Moloto MJ. (2019). Encapsulation of ibuprofen into solid lipid nanoparticles for controlled and sustained release using emulsification solvent evaporation technique. Asian J Pharm Clin Res 12:74–81.
   Google Scholar
• Pai PY, Muo CH, Sung FC, et al. (2016). Angiotensin receptor blockers (ARB) outperform angiotensin-converting enzyme (ACE) inhibitors on ischemic stroke prevention in patients with hypertension and diabetes - a real-world population study in Taiwan. Int J Cardiol 215:114–9.
   PubMed Web of Science ®Google Scholar
• Palei NN, Das MK. (2013). Preparation and characterization of lornoxicam loaded solid lipid nanoparticles made from different lipids. Int J Pharm Pharm Sci 5:438–42.
   Google Scholar
• Parmar B, Mandal S, Petkar KC, et al. (2011). Valsartan loaded solid lipid nanoparticles: development, characterization, and in vitro and ex vivo evaluation. Int J Pharm Sci Nanotechnol 4:1483–90.
   Google Scholar
• Parvez S, Yadagiri G, Gedda MR, et al. (2020). Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis. Sci Rep 10:12243.
   PubMed Web of Science ®Google Scholar
• Patel MN, Lakkadwala S, Majrad MS, et al. (2014). Characterization and evaluation of 5-fluorouracil-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification technique. Am Assoc Pharm Sci 15:1498–508.
   Google Scholar
• Radwan A, El-Lakkany NM, William S, et al. (2019). A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection. Parasites Vectors 12:304.
   PubMed Web of Science ®Google Scholar
• Rana I, Khana N, Ansaria MM, et al. (2020). Solid lipid nanoparticles-mediated enhanced antidepressant activity of duloxetine in lipopolysaccharide-induced depressive model. Colloids Surf, B 194:111209.
   PubMed Web of Science ®Google Scholar
• Remya PN, Damodharan N. (2018). Formulation, development, and characterization of cilnidipine loaded solid lipid nanoparticles. Asian J Pharm Clin Res 11:120–5.
   Google Scholar
• Rohit B, Pal KI. (2013). A method to prepare solid lipid nanoparticles with improved entrapment efficiency of hydrophilic drugs. Curr Nanosci 9:211–20.
   Web of Science ®Google Scholar
• Rubab S, Naeem K, Rana I, et al. (2021). Enhanced neuroprotective and antidepressant activity of curcumin-loaded nanostructured lipid carriers in lipopolysaccharide-induced depression and anxiety rat model. Int J Pharm 603:120670.
   PubMed Web of Science ®Google Scholar
• Schuh RS, Bruxel F, Teixeira HF. (2014). Physicochemical properties of lecithin-based nanoemulsions obtained by spontaneous emulsification or high-pressure homogenization. Quím Nova 37:1193–8.
   Web of Science ®Google Scholar
• Shah R, Eldridge D, Palombo E, Harding IH. (2014). Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential. J Phys Ther Sci 25:59–75.
   Google Scholar
• Shah D, Gupta D, Shah Y. (2017). Effect of lipid and surfactant concentration on cefpodoxime proxetil solid lipid nanoparticle. Eur J Biomed Pharm Sci 4:817–23.
   Google Scholar
• Sharma JB, Bhatt S, Saini V, Kumar M. (2021). Pharmacokinetics and pharmacodynamics of curcumin-loaded solid lipid nanoparticles in the management of streptozotocin-induced diabetes mellitus: application of central composite design. ASSAY Drug Dev Technol 19:262–79.
   PubMed Web of Science ®Google Scholar
• Sharma A, Jain CP. (2010). Preparation and characterization of solid dispersions of Valsartan with Poloxamer 188. Der Pharm Lett 2:54–63.
   Google Scholar
• Sheshala R, Hong GC, Yee WP, et al. (2019). In situ forming phase inversion implants for sustained ocular delivery of triamcinolone acetonide. Drug Deliv Transl Res 9:534–42.
   PubMed Web of Science ®Google Scholar
• Sironi L, Gelosa P, Guerrini U, et al. (2004). Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall. Pharmacol Exp Ther 11:989–95.
   Google Scholar
• Soma D, Attari Z, Reddy MS, et al. (2017). Solid lipid nanoparticles of irbesartan: preparation, characterization, optimization and pharmacokinetic studies. Braz J Pharm Sci 53:1–10.
   Web of Science ®Google Scholar
• Song A, Zhang X, Li Y, et al. (2016). Effect of liquid to solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for transdermal administration. Drug Dev Ind Pharm 42:1308–14.
   PubMed Web of Science ®Google Scholar
• Steiner D, Bunjes H. (2021). Influence of process and formulation parameters on the preparation of solid lipid nanoparticles by dual centrifugation. Int J Pharm X:1–11.
   Google Scholar
• Su JQ, Wen Z, Wen YA, et al. (2016). Modification and stabilizing effects of PEG on resveratrol-loaded solid lipid nanoparticles. J Iran Chem Soc 13:881–90.
   Web of Science ®Google Scholar
• Suhaimi SH, Hisamb RH, Roslic NA. (2015). Effects of formulation parameters on particle size and polydispersity index of orthosiphon stamineus loaded nanostructured lipid carrier. J Adv Res Appl Sci Eng Technol 1:36–9. https://akademiabaru.com/submit/index.php/araset/article/view/1879.
   Google Scholar
• Tamizharasi S, Dubey A, Rathi V, Rathi JC. (2009). Development and characterization of niosomal drug delivery of gliclazide. J Young Pharm 1:205–9.
   Google Scholar
• Tang Q, Nie F, Zhao Q, Chen W. (2022). A merged molecular representation deep learning method for blood-brain barrier permeability prediction. Brief Bioinform 23:bbac357.
   PubMed Web of Science ®Google Scholar
• Tapeinos C, Battaglini M, Ciofani G. (2017). Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases. J Controlled Release 264:306–32.
   PubMed Web of Science ®Google Scholar
• Topal GR, Mészáros M, Porkoláb G, et al. (2020). ApoE-targeting increases the transfer of solid lipid nanoparticles with donepezil cargo across a culture model of the blood–brain barrier. Pharmaceutics 13:38.
   PubMed Web of Science ®Google Scholar
• Yassin AB, Anwer MDK, Mowafy HA, et al. (2010). Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer. Int J Med Sci 7:398–408.
   PubMed Web of Science ®Google Scholar
• Zaini E, Umar S, Firdaus N. (2017). Improvement of dissolution rate of valsartan by solid dispersion system using d (−) mannitol. Asian J Pharm Clin Res 10:288–90.
   Google Scholar